Platinum-based chemotherapy attenuates the effector response of CD8 T cells to concomitant PD-1 blockade.
Annapaola MarinielloTahseen H NastiDaniel Y ChangMasao HashimotoSakshi MalikDaniel McManusJudong LeeDonald J McGuireMaria Andrea CardenasPablo UmañaValeria NicoliniMorie A GertzAnanya SahaZachary S BuchwaldHaydn T KissickEhsan GhoraniSilvia NovelloDario SangioloGiorgio Vittorio ScagliottiSuresh R RamalingamRajesh M ValanparambilPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
In a translational context, we provide a proof-of-concept to consider optimizing the timing of chemo-immunotherapy strategies for improved CD8 T cell functions.